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Mesial temporal sclerosisAbstract Objective: The purpose of this study was to evaluate the role of magnetic resonance
spectroscopy (MRS) in nonlesional temporal lobe epilepsy.
Subjective and methods: Between April 2011 and December 2013, a total of 30 patients having
partial seizures with or without secondary generalization were selected from the Neurology Depart-
ment, Sayed Galal Hospital, Al Azhar University and were studied in this work. All patients
included in the study had clinical history, seizure symptoms, inter-ictal electroencephalography
and neuroimaging findings that were consistent with ‘‘non-lesional epilepsy of temporal lobe ori-
gin”. We mean by non-lesional epilepsy that those cases are not secondary to other pathological
lesions e.g. tumor, vascular insult or post inflammatory. Mesial temporal sclerosis was considered
as nonlesional temporal lobe epilepsy. Each patient was thoroughly asked about the detailed clinical
history after reviewing the referring imaging request and laboratory findings. The MRI and MRS
examinations were performed in all the patients in one session. They were performed at 1.5 T super
conducting system.
Results: MRS was performed in a total of 30 patients. Sixteen patients were males and 14 were
females. The average age of the patients was 32 years (range: 17–47 years). Seventeen patients
(56.7% of total patient number) were found to have clinical and EEG criteria of epileptic activity
related to temporal lobe origin on the right side, while 11 patients (36.7% of total patient number)
were found to have these findings on the left side. Two patients (6.6% of total patients’ number) were
having bilateral temporal lobe epileptic activity. Twenty six patients (about 87% of total patient
218 A.A.K. Aun et al.number) were able to be lateralized withMRS using asymmetry index, 16 cases lateralized to the right
side (about 53% of total patient number) and 10 cases lateralized to the left side (about 34% of total
patient number). The remaining 4 patients (about 13% of total patient number) failed to be lateral-
ized in our study. The sensitivity and specificity of the Conventional MRI and MR spectroscopy for
detection of mesial temporal lobe epilepsy were 60% & 65% and 86% & 83% respectively.
Conclusion: MR spectroscopy is a very sensitive guiding tool in predicting the temporal lobe epilepsy
(TLE) and the side of involvement in patients with TLE even in patients withMR negative studies. It
helps in detecting abnormal spectra of various brainmetabolites.MR spectroscopy has demonstrated
consistent metabolic abnormalities in partial seizures. MRS can also detect bilateral affection with
the ipsilateral side more affected.
 2015 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).1. Introduction
Epilepsy is a common chronic neurological disorder that is
characterized by recurrent unprovoked seizures. These seizures
are transient signs and/or symptoms due to abnormal, exces-
sive or synchronous neuronal activity in the brain. About
50 million people worldwide have epilepsy at any one time.
Epilepsy is usually controlled, but not cured with medication,
although surgery may be considered in difficult cases. How-
ever, over 30% of people with epilepsy do not have seizure
control even with the best available medications. Not all epi-
lepsy syndromes are lifelong – some forms are confined to par-
ticular stages of childhood. Epilepsy should not be understood
as a single disorder, but rather as a group of syndromes with
vastly divergent symptoms but all involving episodic abnormal
electrical activity in the brain (1).
Temporal lobe epilepsy (TLE) is the most common form of
partial epilepsy. Two types of non-lesional medial TLE are dis-
tinguished based on imaging and histopathological findings
(1): TLE with mesial temporal lobe sclerosis (TLE–MTS,
about 60–70%), which is characterized by an atrophied hip-
pocampus with MR signal abnormalities and severe neuronal
loss in the histological examination, and (2) TLE with a nor-
mal appearing hippocampus on the MRI (TLE-no, about
30–40%) and no or mild neuronal loss in the histological
examination (2).
The temporal lobe is the most epileptogenic region of the
brain. In fact, 90% of patients with temporal interictal epilep-
tiform abnormalities on their electroencephalograms (EEGs)
have a history of seizures. Temporal lobe epilepsy (TLE) is
the most frequent cause of focal and refractory seizures. Mesial
temporal sclerosis is the pathologic finding in 65% of temporal
lobectomy specimens from adults with TLE. Mesial temporal
sclerosis displays neuronal loss in the hippocampal formation,
with accompanying astrogliosis. The majority of temporal lobe
seizures originate in the mesial temporal structures, primarily in
the hippocampus, parahippocampal gyrus and amygdala (3).
MRS is a noninvasive technique capable of providing meta-
bolic information about different tissues; also it enables tissue
characterization on a biochemical level surpassing that of con-
ventional magnetic resonance imaging (cMRI). It detects
abnormalities that are invisible to cMRI because metabolic
abnormalities often precede structural changes (4).
Proton MRS has the potential to identify metabolic
abnormalities before structural changes exist, as shown inmany studies that MRS detects abnormalities in patients who
had normal MRI examination, i.e. patients with negative
MRI. Metabolic abnormality may precede the development
of structural lesion, but the connection between the severity
of metabolic disturbance and structural lesion is not straight-
forward (5).
The purpose of this study was to evaluate the role of mag-
netic resonance spectroscopy (MRS) in non-lesional temporal
lobe epilepsy.2. Subjects and methods
2.1. Patient population
Between April 2011 and December 2013, a total of 30 patients
having partial seizures with or without secondary generaliza-
tion were selected from the Neurology Department, Sayed
Galal Hospital, Al Azhar University and were studied in this
work. All patients included in the study had clinical history,
seizure symptoms, inter-ictal electroencephalography and neu-
roimaging findings that were consistent with ‘‘non-lesional epi-
lepsy of temporal lobe origin”. We mean by non-lesional
epilepsy that those cases are not secondary to other patholog-
ical lesions e.g. tumor, vascular insult or post inflammatory.
Mesial temporal sclerosis was considered as nonlesional
temporal lobe epilepsy. In this study the diagnosis of non-
lesional temporal lobe epilepsy (TLE) was based on the follow-
ing criteria: (1) No lesion detected by conventional MR imag-
ing other than mesial temporal sclerosis, (2) Focal ictal
temporal lobe patterns recorded with EEG, and (3) Clinical
features consistent with seizures of temporal lobe origin. The
attack usually begins with an aura of a rising epigastric sensa-
tion and progress to altered consciousness with variable oro-
alimentary manifestations such as lip smacking, chewing and
manual automatisms. This may be accompanied by fear, or
fear may exist alone as the second most common aura. Head
deviation early in the seizure is usually ipsilateral to the seizure
focus, but head deviation may occur late in the seizure which is
contralateral and often a prelude to generalization. Patients
are partially responsive during a seizure and often had post-
ictal confusion or aphasia and the aura is usually remembered
after recovery. Each patient was thoroughly asked about the
detailed clinical history after reviewing the referring imaging
request and laboratory findings.
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The patients were asked to remove any ferromagnetic metals
(such as coins and pins). Pacemaker and any ferromagnetic fix-
ating crews or plate were excluded from this examination. All
patients were informed about the MRI magnets, approximate
duration of MRI and MRS techniques and were instructed not
to move during the examination time.
2.2.1. MR imaging and spectroscopy techniques
2.2.1.1. Patient positioning and preparation for scanning.
Patients were positioned on the MRI examination table in
the supine position. The MRI and MRS examinations were
performed in all patients in one session. They were performed
at 1.5 T super conducting system (Philips Achieva MRI
machine) manufactured at 2009, the Netherlands. The MRI
and 1H MR spectroscopy were performed without sedation.
2.2.1.2. Scan setup and scan parameters. The spectra were all
acquired in conjunction with an MR imaging study of the
brain that included 3-mm coronal T2 spin-echo (SE) images,
3-mm coronal flair images, 3-mm coronal inversion recovery
images through the temporal lobes, and 5-mm axial T1 and
T2 SE images through the entire brain. At the time of scan-
ning, patients are seizure free for at least 3 days.
To obtain MRS technique, scout imaging of the brain in
coronal and sagittal orientations was performed with T1 WI
(Repetition time ms/Echo time ms 500/14, section thickness
3 mm) angulation parallel to the long axis of the hippocampus
for localization of the transverse plane. In addition, an oblique
transverse T2 WI (Repetition time ms/Echo time ms 2550/80,
section thickness 3 mm) was also acquired along the optical
nerve.
The MRS was performed using single voxel, point-resolved
spectroscopy (PRESS) technique. The size of the volume was
mostly 10  20  10 mm3 (left-to-right, anteroposterior, and
feet-to-head directions). The box of volume of interest (VOI)
was positioned parallel to the axis of the hippocampus, cover-
ing the hippocampal region and adjacent mesial temporal
lobes (Fig. 1). Contact with the cerebrospinal fluid and the
temporal bone was avoided.
The spectrum for each location was acquired with a TR of
2 s, a TE of 272 (long) milliseconds, and a total of 192Fig. 1 MR images illustrating hippocampal VOI of 1H MRS in
MRI negative temporal lobe epilepsy patient {Quoted from
Hammen et al. (21)}.acquisitions. The MRS timings and voxel localization were
chosen to minimize the spectral contamination from extracra-
nial adipose tissues.
Localized shimming, phase correction, water suppression
calibration and scan acquisition to eliminate artifacts caused
by eddy currents were performed prior to acquisition of the
spectra.
2.2.1.3. Image evaluation, postprocessing and MRS metabolites
assessment. Automated techniques from the Philips package
were used for global and local shimming and gradient tuning.
The amplitude of the chemical shift selective (CHESS) water
suppression pulse was adjusted to obtain the maximum water
suppression.
The resonances of major metabolites detected were as fol-
lows: the N acetyl aspartate (NAA) peak at 2.02 ppm, the cre-
atine (Cr) and phosphocreatine peak at 3.02 ppm, and the
choline (Cho) peak at 3.20 ppm.
Spectral postprocessing included phase correction to reduce
the noise level, base-line correction to eliminate any draft in
the baseline, peak calibrations and spectral plotting.
The peak areas were integrated for the choline, creatine and
N acetyl aspartate (NAA). Peak-area ratios of NAA/Creatine
+ Choline were calculated for each voxel. The ratio of NAA
to Cr + Cho was calculated as follows: the integral value of
NAA is divided by the sum of the integral values of Cr + Cho.
The ratio of metabolites in concern was considered pathog-
nomonic if the ratio is below 0.71 in either unilateral or bilat-
eral cases (Table 1). When abnormal values were noted
bilaterally, the asymmetry index for lateralization is divided
by 2. The asymmetry index (AI) was calculated as follows:
AI = 2(Rr  Rl)/(Rr + Rl) where Rr is the NAA/(Cho
+ Cr) ratio on the right side and Rl is the NAA/(Cho + Cr)
ratio on the left (Table 2). Lateralization is always to the side
with the lower value.
3. Results
3.1. Baseline clinical details (Table 3)
MRI and MRS examinations were performed in a total of 30
patients. Sixteen patients were males and 14 were females. The
average age of the patients was 32 years (range: 17–47 years).
Seventeen patients (56.7% of total patient number) were found
to have clinical and EEG criteria of epileptic activity related to
temporal lobe origin on the right side, while 11 patients (36.7%
of total patient number) were found to have these findings on
the left side. Two patients (6.6% of total patient number) were
found having bilateral temporal lobe epileptic activity. The
duration of the disease illness at time of performing the MRI
and MRS studies varied from 2 year to 22 years (MeanTable 1 Reference values for parameters obtained by single-
voxel proton MR spectroscopy.
Parameter NAA/Cho + Cr
Minimum 0.73
Maximum 1.13
Abnormal if <0.71
Asymmetry index >0.11
Table 2 Categorization of TLE patients by NAA/Cho + Cr
and an adequate asymmetry index.
Category Label NAA/Cho
+ Cr
Asymmetry
index
Normal None Both
values
normal
<0.11
Pure lateralization Left or right Unilateral
low
>0.11
Bilateral Bi Bilateral
low
<0.05
Bilateral but
lateralized
Bi LT or Bi
RT
Bilateral
low
>0.05
Both sides are normal
but lateralized
Normal LT
or Normal
RT
Both
values
normal
>0.11
Table 3 Baseline clinical data.
Parameter No. of patients
(N:30)
Gender {M/F} 16 (53.4%)/14
(64.6%)
Mean {range} age (year) 32{17–47}
The duration of the disease illness at time of
MRI and MRS studies. Mean {range} years
6.5 (2–22)
Medication controlled/uncontrolled 6 (20%)/24
(80%)
Clinical and EEG criteria related to temporal
lobe epileptic activity
30
– Right side 17 (56%)
– Left side 11 (36%)
– Bilateral 2 (7%)
220 A.A.K. Aun et al.12 years). Most of the patients were on regular medical treat-
ment, and 24 of the total case number (80% of the total patient
number) were controlled; however, 6 cases (20% of the total
patient number) were resistant to medical treatment.
Twenty-six patients (about 87% of total patient number)
were able to be lateralized with MRS using asymmetry index,
16 cases lateralized to the right side (about 53% of total
patient number) and 10 cases lateralized to the left side (about
34% of total patient number) while the remaining 4 patients
(about 13% of total patient number) failed to be lateralized
in our study (Table 4).
3.2. MRI and MRS findings of different encountered patients
Eighteen patients (60% of total patient number) were found to
have positive findings on conventional MRI study, with diag-
nostic criteria denoting hippocampal sclerosis, as regards
bright signal intensity or structural loss. These patients were
classified as follows: 5 patients were found having left side
changes (Fig. 2), 10 patients having right side changes
(Fig. 3) and 3 patients having bilateral changes on both tempo-
ral regions (Fig. 4). The remaining 12 patients (40% of total
patient number) showed normal MRI appearance of both Hip-
pocampal regions with no appreciable signal intensity or struc-
tural loss noted (these were referred to negative MR cases)
(Fig. 5) (Table 5).Sixteen patients (about 53% of total patient number) were
found to have abnormal MRS data on the right mesial tempo-
ral lobe; however, 14 patients (about 47% of total patient
number) had normal data on the right side.
Fifteen patients (about 50% of total patient number) were
found to have abnormal MRS data on the left mesial temporal
lobe, while the other 15 patients had normal data on the left
side.
Twenty-six patients (about 87% of total patient number)
were able to be lateralized with MRS using asymmetry index,
16 case lateralized to the right side (about 53% of total patient
number) and 10 cases lateralized to the left side (about 34% of
total patient number), while the remaining 4 patients (about
13% of total patient number) failed to be lateralized in our
study (Table 6).
On comparing clinical and EEG findings with those of the
MRS data, it was found that 2 cases had bilateral clinical and
EEG findings and one of them lateralized to the right side
(Fig. 6) and the other one failed to be lateralized. It was also
found that 11 cases had left sided clinical and EEG findings
and one of them failed to be lateralized and 10 cases lateral-
ized to the left side. It was also found that 17 cases had right
sided clinical and EEG findings and two of them failed to be
lateralized and 15 cases lateralized to the right side (Fig. 7).
Thus MRS results were nearly consistent with electro-
encephalography results in all patients with no significant dis-
crepancy between the two modalities (Table 7, Fig. 8).
On comparing MRI findings with those of the MRS data it
was found that 18 cases had positive MR changes, whether sig-
nal intensity or structural loss (10 right sided, 5 left sided and 3
cases bilaterally), while the MRI did not find any changes in 12
cases (Negative MRI). However MRS was positive in 26
cases (Fig. 7) with 4 cases failed to be lateralized (Table 8,
Fig. 9).
On comparing abnormal MRS data on the right mesial
temporal lobe with final MRS lateralization using asymmetry
index it was found that 16 cases had abnormal MRS values
(abnormal RT NAA/Cho + Cr). Three of them failed to be
lateralized, one case lateralized to the left side and 12 cases lat-
eralized to the right. The remaining 14 cases had normal MRS
values (normal RT NAA/Cho + Cr) with 4 cases lateralized to
the right side, 9 cases lateralized to the left side and one case
failed to be lateralized (Table 9, Fig. 10).
On comparing abnormal MRS data on the left mesial tem-
poral lobe with final MRS lateralization using asymmetry
index it was found that 15 cases had abnormal MRS values
(abnormal RT NAA/Cho + Cr) with three of them failed to
be lateralized, 8 cases lateralized to the left side and 4 cases lat-
eralized to the right. The other 15 cases had normal MRS val-
ues (normal RT NAA/Cho + Cr) with 12 cases lateralized to
the right side, 2 cases lateralized to the left side and one case
failed to be lateralized (Table 10, Fig. 11).
MRS revealed abnormal metabolites in 24 cases (80%) with
lateralization in 20 cases (67%) and abnormal ratios in 4 cases
with ve asymmetry index. In the remaining 6 cases, the MRS
revealed normal metabolite ratios but +ve asymmetry index
aiding in lateralization. Therefore correct lateralization was
achieved in 26 cases (87%). Failure of lateralization was seen
in 4 cases, 2 of them were due to bilateral affection, and the
other 2 ones were wrong lateralization. MRS detected bilateral
affection in 5 cases, 4 cases were right sided in EEG and 1 case
was left sided in EEG.
Table 4 Descriptive report.
Lateralization Age Onset RT NAA/Cho + Cr LT NAA/Cho + Cr Asymmetry index
LT Mean 34.10 6.50 0.80 0.63 0.21
N 10.00 10.00 10.00 10.00 10.00
SD 6.87 1.90 0.11 0.07 0.07
No Mean 36.25 6.00 0.61 0.61 0.06
N 4.00 4.00 4.00 4.00 4.00
SD 9.11 2.58 0.14 0.13 0.02
Rt Mean 31.69 6.75 0.63 0.77 0.25
N 16.00 16.00 16.00 16.00 16.00
SD 9.39 4.61 0.09 0.08 0.17
Total Mean 33.10 6.57 0.69 0.70 0.21
N 30.00 30.00 30.00 30.00 30.00
SD 8.47 3.59 0.13 0.11 0.14
Fig. 2 (a) Left hippocampal (mesial) sclerosis. Female patient, 32 years old, complaining of complex partial seizures, of temporal lobe
origin for 6 years well controlled by AED. EEG (not shown) revealed left temporal focus. Coronal T2 weighted (upper row) and coronal
Fluid Attenuation Inversion Recovery, FLAIR, (lower row) images show left hippocampal atrophy (black open arrow) and bright signal
involving the left hippocampus (white open arrow).
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Temporal lobe epilepsy (TLE) is the most common form of
partial epilepsy. Two types of non-lesional medial TLE are dis-
tinguished based on imaging and histopathological findings:
(1) TLE with mesial temporal lobe sclerosis (TLE–MTS, about
60–70%), which is characterized by an atrophied hippocampuswith MR signal abnormalities and severe neuronal loss in the
histological examination, and (2) TLE with a normal appear-
ing hippocampus on the MRI (TLE-no, about 30–40%) and
no or mild neuronal loss in the histological examination. The
differences between the two TLE types, however, are not
restricted to the hippocampus and its appearance in the MRI
or histopathological preparation. Recent neuroimaging studies
Fig. 3 Right hippocampal (mesial) sclerosis. Male patient, 26 years old, complaining of epileptic fits for 6 years not well controlled by
AED. EEG (not shown) revealed right frontotemporal focus. MRI findings (not shown) revealed right hippocampal atrophy and
increased signals. MRS (A) right and (B) left mesial regions showing reduced NAA and elevated Cho peak on the right side and normal
peaks on the left side. On the right side: NAA/Cho + Cr = 0.69. On the left side: NAA/Cho + Cr = 0.75. Asymmetry index = 0.08,
lateralizing to the right side.
222 A.A.K. Aun et al.have shown that structural and functional abnormalities exist
beyond the hippocampus and even beyond the temporal lobe,
and that the two groups not only differ regarding severity of
these abnormalities but more importantly also regarding their
distribution. These findings, together with other crucial clinical
differences between TLE–MTS and TLE-no, e.g. history of
febrile seizures, age at onset of epilepsy, initial ictal zone or
success of epilepsy surgery, suggest that TLE-no is more than
just a milder form of TLE–MTS but eventually even a distinct
entity of TLE (2).MRS provides in vivo biochemical information. The peaks
on the spectra obtained correspond with various metabolites,
normal and abnormal, which may be identified precisely.
Although peaks from non-identical molecules may overlap,
in clinical practice, this is not usually an issue where brain
metabolites are concerned, particularly when scanning at
1.5 T (at higher field strengths this is not necessarily the case)
(6).
In this research, MRS (using 1.5 T magnet) was used in
evaluating the two types of non-lesional temporal lobe epilepsy
Fig. 4a Bilateral hippocampal (mesial) sclerosis. Male patient, 43 years old, presented by epileptic fits for 8 years, not well controlled by
AED. EEG (not shown) revealed left temporal focus. Coronal T2 weighted (upper row) and coronal Fluid Attenuation Inversion
Recovery, FLAIR, (lower row) images show bilateral hippocampal atrophy (black open arrow) and increased signals (open white arrows).
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Special emphases were made on the temporal lobe, mainly its
medial parts and not including extra-temporal areas. Thus
we believe that the mentioned findings of this study are valid
only for seizures originating in the temporal lobes.
Proton MRS has the potential to identify metabolic abnor-
malities before structural changes exist, as shown in many
studies that MRS detects abnormalities in patients who had
normal MRI examination, i.e. patients with negative MRI.
Metabolic abnormality may precede the development of struc-
tural lesion, but the connection between the severity of meta-
bolic disturbance and structural lesion is not straightforward
(5).
Several metabolite ratios, such as NAA/(Cho+Cr), NAA/Cr,
and NAA/Cho are used. Clear concordant lateralization is
best achieved with NAA/(Cho + Cr) followed by NAA/Cho.
The use of asymmetry index (AI) improved the lateralizing
capabilities of the technique especially in bilateral abnormal
ratios. The asymmetry index is calculated from the maximum
left to right difference found in normal individuals. When
bilateral pathologic values are used the asymmetry index
necessary for lateralization was divided by 2 (7).
In this study, different metabolites concentration, metabo-
lite ratios alteration and asymmetry index were used for the
evaluation of temporal lobe abnormality and lateralization.
On comparing MRI findings with those of the MRS data it
was found that 18 out of 30 cases had positive MR changes,
whether signal intensity or structural loss (10 right side, 5 leftsided and 3 cases bilaterally), while the MRI did not find any
changes in 12 cases (Negative MRI). However MRS was pos-
itive in 26 cases with 4 cases failed to be lateralized.
The side of maximum NAA reduction often coincides with
the side of EEG abnormality. A major clinical challenge per-
tains to patients classified as having nonlesional epilepsy.
MRS may be helpful in the identification of the seizure focus
in refractory focal epilepsy patients without obvious MR imag-
ing abnormalities. These abnormalities consisted of decreased
NAA and increased Cho, lateralized to the seizure focus, sim-
ilar to the patients with hippocampal sclerosis (8). Mesial tem-
poral sclerosis characterized by loss of neurons, atrophy and
gliosis is found in the resected hippocampal formation of up
to 70% of patients receiving temporal lobectomy for intract-
able TLE. NAA is believed to be located primarily within neu-
rons, and the loss of NAA signals is consistent with neuronal
loss or damage. While the basis for the increase in the Cho and
Cr signals remains unclear, one possible explanation is pro-
vided by the study of neuronal cells, which showed that the
concentrations of Cho and Cr are much higher in astrocyte
and oligodendrocyte preparations than in cerebellar granule
neurons. It may be that the changes in Cho and Cr reflect reac-
tive astrocytosis. Thus, the decrease in NAA=(Cho C Cr)
ratios in ipsilateral MTLs may reflect the neuronal loss and
reactive gliosis as observed in mesial temporal sclerosis in
TLE (5).
Differentiating partial (Focal) from generalized seizures is a
primary step in evaluating seizure patients. Those with partial
Fig. 4b MRS (A) right and (B) left mesial temporal regions showing reduced NAA and elevated Cho peaks on both sides. On the right
side: NAA/Cho + Cr = 0.53. On the left side: NAA/Cho + Cr = 0.48. Asymmetry index = 0.09 indicating lateralization toward the left
side.
224 A.A.K. Aun et al.seizures are more likely to have a focal abnormality in the
brain that could be detected by different imaging modalities
and potentially surgical cure may have place, than those with
generalized form. In general, patients with temporal lobe epi-
lepsy respond better to therapy, whether medical or surgical
than those with extra-temporal seizures (9).
Temporal lobe epilepsy (TLE) is the most prevalent cause
of focal epilepsy that is resistant to medical treatment. Most
imaging modalities were focused on temporal lobe epilepsy
as surgical intervention can provide excellent outcome in many
patients. Surgery became the only effective option, where sur-
gical resection of the affected hippocampus and the anterior
part of the temporal lobe, cure up to 90% of cases, however,
requires accurate pre-operative lateralization of the epileptic
focus. Patients candid for surgery are those who have
recurrent seizure attacks resistant to medication that havesignificant impact on their life and reflected to their family
and society. (10).
The results from an individual’s clinical and neurophysio-
logical examinations that are both interpretable and congruent
were regarded as the ‘‘gold standard” for localizing the epilep-
togenic area. This usually involves a combination of video
monitoring and EEG recording, which is generally performed
in a hospital setting often for a prolonged period of time and
after reduction of medication. Furthermore, in some patients
with no clear localization or lateralization of the epileptogenic
area, an invasive neurophysiological approach is required for
further clarification. This is often the case in patients who
are either diagnosed to have bilateral TLE or who have shown
conflicting clinical and EEG-localizing features. (11).
Measures needed for accurate preoperative localization of
seizure focus are as follows:
Fig. 5a Bilateral hippocampal (mesial) sclerosis. Female patient, 38 years old, presented by epileptic fits for 4 years well controlled by
AED. EEG (not shown) revealed right frontotemporal focus. Coronal T2 weighted (upper 2 rows) and coronal Fluid Attenuation
Inversion Recovery, FLAIR, (lower 2 rows) images show normal hippocampal size and signals bilaterally.
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(b) EEG.
(c) Neuro-physiological studies.
(d) Imaging techniques, including; SPECT, PET and MRI
techniques, (conventional MRI and MRS).
(e) If the above fails then invasive monitoring by intracra-
nial electrodes may be required.
Although the high tissue characterization and the multi-
planner capability of the magnetic resonance imaging in eval-
uation of seizure patients, some patients with temporal lobe
epilepsy still appear to have normal MR appearance that is
to say negative MRI (12).
The search for a highly accurate, non-invasive method for
localization of seizure focus led to investigate the usefulness
of Magnetic Resonance Spectroscopy in seizure field (13).The Magnetic resonance spectroscopy (MRS) is a non-
invasive modality that provides metabolic information about
the brain tissue and enables tissue characterization on a bio-
chemical level surpassing that of the conventional MR imaging
(cMRI). MR spectroscopy is also able to detect abnormalities
that are invisible to cMRI, as metabolic abnormalities often
precede structural changes. (14).
We found no specific contraindications other than those of
MRI and could be added to MRS technique and no special
instructions were needed apart from patient motion during
data acquisition of MRS. MRS and MRI were done in one ses-
sion in our work.
Most reported studies were performed using a single voxel
and long TEs (15) similar to the technique used in our study.
Previous studies have shown that a reduced NAA/Cho + Cr
ratio allows for lateralization of the epileptogenic focus in
Fig. 5b MRS (A) right and (B) left mesial temporal regions showing reduced NAA and elevated Cho peaks on both sides. On the right
side: NAA/Cho + Cr = 0.59. On the left side: NAA/Cho + Cr = 0.67. Asymmetry index = 0.13 indicating lateralization toward the
right side.
Table 5 Different encountered spectral changes and MRI in
temporal lobes.
Side NAA/Cho + Cr MRI
Right Normal: 14 (47%) Normal: 17 (57%)
Abnormal: 16 (53%) Abnormal: 10 (33%)
Left Normal: 15 (50%) Normal: 22 (73%)
Abnormal: 15 (50%) Abnormal: 5 (16.7%)
Bilateral Normal: 12 (40%) Normal: 12 (40%)
Abnormal: 3 (10%) Abnormal: 3 (10%)
226 A.A.K. Aun et al.most patients in accordance with EEG results. Contra lateral
values were often taken as internal references.
We elected to use clinical and EEG seizure localization as
the standard against data which were obtained by proton
MRS and MRI. On comparing lateralization of TLE
by MRS with the gold standard EEG, We found that EEG
and MRS results were highly concordant.
We consider the ratio of reduction of NAA level in relation
to the level of Cr + Cho was considered significant if this ratio
is below 0.71 and the percentage of ratio reduction difference
between the affected side and the normal side, referred as ‘‘in-
dex of asymmetry”, as stated by Burtscher and Holtas (12),
Table 6 Asymmetry index.
Asymmetry index (mesial) No of patients Percentage (%)
Positive 26 87
Negative 4 13
LT. Spect lateralization 10 33.33
RT. Spect lateralization 16 53.33
No spect lateralization 4 13.33
Role of magnetic resonance spectroscopy 227was considered significant if more than 11% that is to say the
compared ratio between the affected and the normal sides, and
in these cases it is possible to localize epileptic focus in large
category of patients. In bilateral cases of TLE, evaluating both
temporal lobes by MRS reveals that the ratio of reduction wasFig. 6 Bilateral hippocampal (mesial) sclerosis. Male patient, 33 year
for treatment 4 years back. EEG (not shown) revealed bilateral epilepto
MRS (A) right and (B) left mesial regions showing reduced NAA and
side. On the right side: NAA/Cho + Cr = 0.59. On the left side: NA
right side.also reduced below 0.71 in both sides and the index of asym-
metry used for lateralization of the dominant epileptic focus
reaches 5.5%.
In this study, like other studies, such as stated by Burtscher
and Holtas (12) and others, the ratio of reduction of NAA to
Cr + Cho was more important than the absolute decreased
intensity value of NAA alone. The critical level of ratio reduc-
tion of N-acetyl aspartate in relation to Creatine + Choline
(NAA/Cr + Cho) was considered pathognomonic if below
0.71 in unilateral cases of temporal lobe epilepsy as compared
to the contra-lateral normal side.
Lateralization findings on epileptic focus by MR spec-
troscopy agreed with the data obtained from the clinical and
EEG and conventional MR imaging in most patients under
study.s old, complaining of temporal lobe epilepsy for 11 years, resistive
genic dysfunction with normal MRI findings of both hippocampi.
elevated Cho peak on the right side and normal peaks on the left
A/Cho + Cr = 0.67. Asymmetry index = 0.13, lateralizing to the
Fig. 7 Right hippocampal (mesial) sclerosis. Female patient, 17 years old, complaining of epileptic fits for 2 years well controlled by
AED. EEG (not shown) revealed right frontotemporal focus with normal MRI findings of both hippocampi. MRS (A) right and (B) left
mesial regions showing reduced NAA and elevated Cho peak on the right side and normal peaks on the left side. On the right side:
NAA/Cho + Cr = 0.47. On the left side: NAA/Cho + Cr = 0.75. Asymmetry index = 0.46, lateralizing to the right side.
228 A.A.K. Aun et al.In our study 30 cases have been examined having abnormal
EEG, 17 cases with RT sided EEG, 11 cases with LT sided
EEG and 2 cases of bilateral EEG abnormalities. In lateraliza-
tion using single voxel 1H MRS, the NAA/Cho + Cr ratio was
achieved in 26 cases (87.7%), 16 cases at the right side (53%)
and about 10 cases at the left side (33%). Four cases had failed
lateralization.
Conelly et al. (16) investigated 25 cases of TLE using single
voxel 1H MRS. Lateralization was possible in 18 cases using
the NAA/Cho + Cr ratio (72%). The mean NAA/Cho + Cr
ratios were significantly less in patients with TLE, with evencontralateral affection in some patients with the ipsilateral side
more affected.
In our study, we have abnormal NAA/(choline + Cr) in 24
cases (80%) and 6 cases (20%) have normal values at both
sided, but all 6 cases could be lateralized with the use of asym-
metry index which are matching well with EEG lateralization,
4 to the right and two to the left side. All these cases are
controlled.
In our study, clear lateralization to the ipsilateral side is
predicted by EEG, with an abnormal NAA/Cho + Cr on
the ipsilateral side only (in 15 cases or 50%). The use of
Table 7 EEG with spect. Lateralization.
EEG/spect lateralization Lateralization Total
LT lateralization No lateralization RT lateralization
EEG Bil No. 0 1 1 2
% 0.0 25.0 6.3 6.7
LT No. 10 1 0 11
% 100.0 25.0 0.0 36.7
RT No. 0 2 15 17
% 0.0 50.0 93.8 56.7
Total No. 10 4 16 30
% 100.0% 100.0 100.0 100.0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
80.0
90.0
100.0
110.0
Rt Lateralization No Lateralization LT Lateralization
0.0
25.0
100.0
6.3
25.0
0.0
93.8
50.0
0.0
Lt EEG Bilateral EEG Rt EEG%  
Fig. 8 Chart showing EEG with Spect. Lateralization.
Role of magnetic resonance spectroscopy 229asymmetry index resulted in addition of 11 cases, 5 cases have
bilateral normal values (3 of them are not controlled) and 6
cases have normal values bilaterally but complaining and have
EEG lateralization. Lateralization could be achieved in 26
(87.7%).
Achten et al. (17) investigated 25 cases. Clear lateralization
to the ipsilateral side is predicted by EEG and MR imaging,
with an abnormal NAA/Cho + Cr on the ipsilateral side only
(in 13, or 62%, of 21 patients). The use of asymmetry index
resulted in addition of 4 cases. Lateralization could be
achieved in 17 (81%) of the 21 patients. Because no false later-
alization occurred with this definition of asymmetry, weTable 8 MRI with spect lateralization.
MRI/lateralization Lateralization
LT lateralization
MRI Bilateral No. 2
% 20.0
LT No. 5
% 50.0
Normal (ve) No. 3
% 30.0
RT No. 0
% 0.0
Total No. 10
% 100.0believe that such use of the asymmetry index may be a way
out of too many bilateral normal or abnormal values of later-
alization. Important note in this study is use of intermediate
TE 135 ms.
Cendes et al. (18) investigated 100 patients with TLE using
1H MRS and MRI volumetry. Lateralization was correctly
obtained in 86% using MRS alone. The additional use of an
asymmetry index for lateralization purposes was proposed by
Burtscher and Holtas (12). Kuzniecky (19) has proposed the
use of a lowered asymmetry index of 0.05 for patients with
bilaterally low NAA/Cho + Cr.
This resulted in additional lateralization in 5 cases in our
study with bilaterally abnormal NAA/Cho + Cr ratios as well
as 6 cases of normal values.
In summary, the use of an asymmetry index improved the
lateralizing capacity of the parameter NAA/Cho + Cr derived
from the mesial temporal lobes of patients with unilateral tem-
poral lobe epilepsy by means of single voxel proton MR spec-
troscopy as frequent bilateral temporal lobe involvement was
found.
Beyond its sensitivity in lateralizing single foci 1H MRS is a
sensible method to detect bilateral affections which might be
underdiagnosed in conventional MRI (20). In our study
MRS detected bilateral affection in 5 cases with 3 cases RT
sided EEG abnormality, 1 case with LT sided EEG abnormal-
ity and 1 case with bilateral EEG abnormality (5 cases 16.7%).
The NAA/Cho + Cr ratio on the ipsilateral side according to
the EEG was lower than that of the contralateral side.Total
No lateralization RT lateralization
0 1 3
0.0 6.3 10.0
0 0 5
0.0 0.0 16.7
3 6 12
75.0 37.5 40.0
1 9 10
25.0 56.3 33.3
4 16 30
100.0 100.0 100.0
0 
10
20
30
40
50
60
70
80
Bilateral LT Normal (-ve) RT
20
50
30
0 0 0 
75
25
6.3
0 
37.5
56.3
LT Lateralization No Lateralization Rt Lateralization%
Fig. 9 Chart showing MRI with spect. lateralization.
Table 10 LT NAA/Cho + Cr with lateralization.
NAA/Cho + Cr/lateralization lateralization Total
LT No RT
LT NAA/Cho
+ Cr
Normal No. 2 1 12 15
% 20.0 25.0 75.0 50
Abnormal No. 8 3 4 15
% 80.0 75.0 25.0 50
Total No. 10 4 16 30
% 100.0 100.0 100.0 100.0
10
20
30
40
50
60
70
80
90
100
110
Lt No Rt
20
25
75
80
75
25
Normal Abnormal%  
Fig. 11 Chart showing Lt. NAA/Cho + Cr with lateralization.
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90
25 25
10
75 75
Normal Abnormal%  
Fig. 10 Chart showing Rt. NAA/Cho + Cr with lateralization.
Table 9 RT NAA/Cho + Cr with lateralization.
NAA/Cho + Cr/lateralization Lateralization Total
LT No RT
RT NAA/Cho
+ Cr
Normal No. 9 1 4 14
% 90.0 25.0 25.0 46.7
Abnormal No. 1 3 12 16
% 10.0 75.0 75.0 53.3
Total No. 10 4 16 30
% 100.0 100.0 100.0 100.0
230 A.A.K. Aun et al.Previous studies (14) stated that the mean ipsilateral hip-
pocampal body NAA/Cho + Cr ratio was 0.62 ± 0.11 com-
pared with 0.79 ± 0.11 in the contralateral side. In our study
the ipsilateral NAA/Cho + Cr ratio is 0.63 ± 0.09 and 0.63
± 0.07 in the RT sided and LT sided with a P value
<0.001. The contralateral NAA/Cho + Cr ratio is 0.77
± 0.08 and 0.8 ± 0.11 in the RT sided and LT sided
respectively.
Proton MRS revealed the bilateral temporal reduction in
NAA/Cho + Cr in TLE patients with unilateral EEG focus.
The potential for seizure generation was correlated with the
NAA/Cho + Cr reduction not only in the ipsilateral MTL
but also in the contralateral MTL.5. Conclusion
MR Spectroscopy is a very sensitive guiding tool in predicting
the TLE and the side of involvement in patients with TLE even
in patients with MR negative studies.
It helps in detecting abnormal spectra of various brain
metabolites. MR spectroscopy has demonstrated consistent
metabolic abnormalities in partial seizures.
The side of maximum reduced NAA/Cho + Cr ratio often
coincides with the side of EEG abnormality. MRS can also
detect bilateral affection with the ipsilateral side more affected.
The abnormal metabolite ratios can be found to affect the
brain tissue beyond the hippocampus reaching to the
neocortex.
The use of asymmetry index (AI) improved the lateralizing
capabilities of the technique especially in bilateral abnormal
ratios. The asymmetry index can also be used in patients with
normal metabolite ratios, yet with proved EEG findings to pre-
dict the side of involvement. The affected altered metabolite
ratios are more evident in those patients who are not well con-
trolled by the anti-epileptic drugs than those who are well
controlled.Conflict of interest
We have no conflict of interest to declare.
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